Revenue
-
Net Income
-$161.2M
▼ 107.7% YoY
EPS
$-18.56
▲ 82.4% YoY
Cash
$46.7M
▲ 22.2% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
GILLIS JONATHAN CAAO and PAO | Sell | Apr 28, 2026 | 17.2K | $30.33 | $523K | Form 4 ↗ |
GILLIS JONATHAN CAAO and PAO | Sell | Apr 28, 2026 | 700 | $30.83 | $22K | Form 4 ↗ |
GILLIS JONATHAN CAAO and PAO | Sell | Apr 27, 2026 | 7.9K | $28.94 | $229K | Form 4 ↗ |
GILLIS JONATHAN CAAO and PAO | Sell | Apr 27, 2026 | 29.6K | $29.60 | $877K | Form 4 ↗ |
GILLIS JONATHAN CAAO and PAO | Sell | Apr 27, 2026 | 14.4K | $30.46 | $437K | Form 4 ↗ |
Kreitzer Anatol Chief Discovery Officer | Sell | Apr 27, 2026 | 8.3K | $28.96 | $242K | Form 4 ↗ |
Kreitzer Anatol Chief Discovery Officer | Sell | Apr 27, 2026 | 29.3K | $29.63 | $867K | Form 4 ↗ |
Kreitzer Anatol Chief Discovery Officer | Sell | Apr 27, 2026 | 7.8K | $30.50 | $239K | Form 4 ↗ |
Hanson Kristopher General Counsel | Sell | Apr 16, 2026 | 73 | $27.01 | $2K | Form 4 ↗ |
Hanson Kristopher General Counsel | Sell | Apr 16, 2026 | 225 | $27.49 | $6K | Form 4 ↗ |
Setia Vishwas Chief Financial Officer | Sell | Apr 16, 2026 | 29 | $27.01 | $783 | Form 4 ↗ |
Setia Vishwas Chief Financial Officer | Sell | Apr 16, 2026 | 87 | $27.49 | $2K | Form 4 ↗ |
Lillie James Woodruff Chief Scientific Officer | Sell | Apr 16, 2026 | 686 | $27.01 | $19K | Form 4 ↗ |
Lillie James Woodruff Chief Scientific Officer | Sell | Apr 16, 2026 | 2.1K | $27.49 | $58K | Form 4 ↗ |
Foff Erin Pennock Chief Medical Officer | Sell | Apr 16, 2026 | 288 | $27.01 | $8K | Form 4 ↗ |
Foff Erin Pennock Chief Medical Officer | Sell | Apr 16, 2026 | 881 | $27.49 | $24K | Form 4 ↗ |
Kroeger Christopher A. Chief Executive Officer | Sell | Apr 16, 2026 | 2.5K | $27.01 | $67K | Form 4 ↗ |
Kroeger Christopher A. Chief Executive Officer | Sell | Apr 16, 2026 | 7.6K | $27.49 | $208K | Form 4 ↗ |
Kreitzer Anatol Chief Discovery Officer | Sell | Apr 15, 2026 | 3.3K | $26.61 | $88K | Form 4 ↗ |
GILLIS JONATHAN CAAO and PAO | Sell | Apr 15, 2026 | 3.6K | $26.61 | $96K | Form 4 ↗ |
Hanson Kristopher General Counsel | Sell | Apr 15, 2026 | 1.5K | $26.80 | $41K | Form 4 ↗ |
Setia Vishwas Chief Financial Officer | Sell | Apr 15, 2026 | 2.8K | $26.87 | $75K | Form 4 ↗ |
Lillie James Woodruff Chief Scientific Officer | Sell | Apr 15, 2026 | 1.7K | $26.82 | $46K | Form 4 ↗ |
Foff Erin Pennock Chief Medical Officer | Sell | Apr 15, 2026 | 2.0K | $26.84 | $55K | Form 4 ↗ |
Kroeger Christopher A. Chief Executive Officer | Sell | Apr 15, 2026 | 9.1K | $26.93 | $246K | Form 4 ↗ |
Malenka Robert C. | Sell | Apr 15, 2026 | 8.6K | $26.90 | $231K | Form 4 ↗ |
Malenka Robert C. | Sell | Feb 24, 2026 | 736 | $18.15 | $13K | Form 4 ↗ |
Malenka Robert C. | Sell | Feb 23, 2026 | 10.8K | $18.39 | $198K | Form 4 ↗ |
Malenka Robert C. | Sell | Feb 23, 2026 | 476 | $19.06 | $9K | Form 4 ↗ |
Malenka Robert C. | Sell | Feb 20, 2026 | 2.2K | $18.03 | $40K | Form 4 ↗ |
Pavlov George | Buy | Feb 20, 2026 | 9.9K | $17.86 | $177K | Form 4 ↗ |
Pavlov George | Buy | Feb 19, 2026 | 4.4K | $17.57 | $78K | Form 4 ↗ |
Pavlov George | Buy | Feb 18, 2026 | 10.7K | $17.48 | $186K | Form 4 ↗ |